SPARK Impact is a multi-fund manager located in the UK and authorised and regulated by the Financial Conduct Authority. The firm is authorised to undertake portfolio fund management as well as being authorised as a Small authorised Sub Threshold Alternative Investment fund manager.
SPARK invests in companies and opportunities through all stage of their development from early stage to growth to providing capital for expansion. It benefits from a team that is able to cover all business sectors with experience in equity, venture debt and mezzanine finance. Spark offers help to create world class businesses and the best investment opportunities with experience in public, private and public/private funds.
Our role is to identify suitable investment opportunities, conduct due diligence, negotiate, structure investment transactions, and monitor and manage investments until exit.
The Enterprise Development Scheme – Isle of Man
SPARK is managing the £50m Enterprise Development Scheme (EDS), which offers investment to businesses based on or relocating to the Isle of Man.
The investment period is over five-years and the funds are to be used in businesses that seek to create jobs on the Island, the fund can invest as equity, venture debt or microloan.
The scheme will provide support to small and medium sized businesses, and is also designed to assist with the expansion of established and new to Island businesses, particularly those providing their goods and services to off-Island customers.
SPARK are managing the two elements of the fund,
Accelerator (investment in on-island businesses): Loan and equity investment for Small to Medium Enterprises (typically with 5-20 employees) entering their next growth phase.
Relocator: Loan and equity investment (of up to £1million) for establishing or relocating companies to the island
The North West Fund for Biomedical
The North West Fund for Biomedical is a £30m fund designed to provide flexible equity package(s) for high growth businesses operating within the biomedical sector, these include:
pharmaceuticals (research, development and manufacture of drugs and biopharmaceuticals);
clinical research organisations;
contract manufacturing organisations;
analytical services and sciences
healthcare technologies, medical devices and implantable's.
SPARK Impact manages the North West Fund for Biomedical, providing finance from £50,000 to £1.5m to businesses to support a broad range of needs from start-up and early stage development through to expansion plans for trading businesses.
The original £25m fund was increased to £30.6m resulting in further follow on investment in 23 existing investee companies. The fund is now fully invested as of December 2015.